Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 11
2003 7
2004 9
2005 9
2006 10
2007 9
2008 5
2009 9
2010 6
2011 6
2012 7
2013 7
2014 11
2015 11
2016 12
2017 6
2018 9
2019 6
2020 8
2021 11
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

159 results

Results by year

Filters applied: . Clear all
Page 1
Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice.
Gonzalo-Consuegra C, Santos-García I, García-Toscano L, Martín-Baquero R, Rodríguez-Cueto C, Wittwer MB, Dzygiel P, Grether U, de Lago E, Fernández-Ruiz J. Gonzalo-Consuegra C, et al. Among authors: fernandez ruiz j. Biomed Pharmacother. 2024 May;174:116473. doi: 10.1016/j.biopha.2024.116473. Epub 2024 Mar 24. Biomed Pharmacother. 2024. PMID: 38522237 Free article.
Preclinical investigation in FAAH inhibition as a neuroprotective therapy for frontotemporal dementia using TDP-43 transgenic male mice.
Santos-García I, Rodríguez-Cueto C, Villegas P, Piscitelli F, Lauritano A, Shen CJ, Di Marzo V, Fernández-Ruiz J, de Lago E. Santos-García I, et al. Among authors: fernandez ruiz j. J Neuroinflammation. 2023 May 6;20(1):108. doi: 10.1186/s12974-023-02792-z. J Neuroinflammation. 2023. PMID: 37149645 Free PMC article.
Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure-Activity Relationship.
Figuerola-Asencio L, Morales P, Zhao P, Hurst DP, Sayed SS, Colón KL, Gómez-Cañas M, Fernández-Ruiz J, Croatt MP, Reggio PH, Abood ME, Jagerovic N. Figuerola-Asencio L, et al. Among authors: fernandez ruiz j. ACS Med Chem Lett. 2022 Dec 2;14(1):18-25. doi: 10.1021/acsmedchemlett.2c00325. eCollection 2023 Jan 12. ACS Med Chem Lett. 2022. PMID: 36655130 Free PMC article.
Endocannabinoid-Binding Receptors as Drug Targets.
Gómez-Cañas M, Rodríguez-Cueto C, Satta V, Hernández-Fisac I, Navarro E, Fernández-Ruiz J. Gómez-Cañas M, et al. Among authors: fernandez ruiz j. Methods Mol Biol. 2023;2576:67-94. doi: 10.1007/978-1-0716-2728-0_6. Methods Mol Biol. 2023. PMID: 36152178
Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis.
Burgaz S, García C, Gonzalo-Consuegra C, Gómez-Almería M, Ruiz-Pino F, Unciti JD, Gómez-Cañas M, Alcalde J, Morales P, Jagerovic N, Rodríguez-Cueto C, de Lago E, Muñoz E, Fernández-Ruiz J. Burgaz S, et al. Among authors: fernandez ruiz j. Molecules. 2021 Dec 16;26(24):7643. doi: 10.3390/molecules26247643. Molecules. 2021. PMID: 34946726 Free PMC article.
159 results